Synapse - Genitourinary Oncology Service

Search Within

Genitourinary Oncology Service

Results (5692)

Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with (18)f-fluoromisonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases

Meeting Abstract

Lee, N.; Jensen, J.; Schoder, H.; Wang, Y.; Fury, M.; Pfister, D. G.; Stambuk, H.; Humm, J.; Koutcher, J.; Shukla-Dave, A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A randomized, phase II study of ATN-224 in patients with biochemically relapsed, hormone-naive prostate cancer: A DOD/PCF Prostate Cancer Clinical Trials Consortium trial

Meeting Abstract

Lin, J.; Beer, T. M.; Ryan, C. J.; Mathew, P.; Wilding, G.; Morris, M.; Callahan, J. A.; Gordon, G.; Reich, S.; Carducci, M. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma

Meeting Abstract

Kroog, G. S.; Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Ishill, N. M.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Prevention of hip fractures in older men receiving androgen deprivation therapy for prostate cancer: A cost-effectiveness analysis

Meeting Abstract

Ito, K.; Elkin, E.; Morris, M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of sunitinib on a continuous dosing schedule in patients (pts) with relapsed or refractory urothelial carcinoma (UC)

Meeting Abstract

Gallagher, D. J.; Milowsky, M. I.; Gerst, S. R.; Tickoo, S.; Ishill, N.; Regazzi, A.; Trout, A.; Bajorin, D. F.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Circulating tumor cells (CTC) in patients with metastatic castration-resistant prostate cancer (CRPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy

Meeting Abstract

Fleisher, M.; Danila, D. C.; Leversha, M.; Rathkopf, D.; Slovin, S.; Anand, A.; Koscuiszka, M.; Haqq, C.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts

Meeting Abstract

Feldman, D. R.; Sheinfeld, J.; Bajorin, D. F.; Fischer, P.; Turkula, S.; Ishill, N.; Patil, S.; Bains, M.; Bosl, G. J.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Quality of life (QOL) with sunitinib versus interferon-alfa (IFN-α) as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): Final results

Meeting Abstract

Cella, D.; Michaelson, M. D.; Cappelleri, J. C.; Bushmakin, A. G.; Charbonneau, C.; Kim, S. T.; Li, J. Z.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II multicenter study of abiraterone acetate (AA) plus prednisone therapy in docetaxel-treated castration-resistant prostate cancer (CRPC) patients (pts): Impact of prior ketoconazole (keto)

Meeting Abstract

Danila, D. C.; de Bono, J.; Ryan, C. J.; Denmeade, S.; Smith, M.; Taplin, M.; Bubley, G.; Molina, A.; Haqq, C.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Pain and analgesic use in men with metastatic prostate cancer

Meeting Abstract

Basch, E. M.; Sit, L.; Fruscione, M.; Burke, L.; Kane, R.; George, D.; Carducci, M. A.; Matthew, P.; Beer, T. M.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save